Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center by Castro, Marcelo Dias de et al.
hematol transfus cell ther. 2 0 1 8;40(2):132–135
www.rbhh.org
Hematology, Transfusion and Cell Therapy
Original article
Infectious diarrhea in autologous stem cell
transplantation: high prevalence of coccidia
in a South American center
Marcelo Dias de Castroa,b, Julio Maria Chebli a, Luciano José Costac,
Katia Regina Lopes Alvesa,∗, Angelo Atallaa, Abrahao E. Hallack Netoa
a Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, MG, Brazil
b Faculdade de Medicina de Barbacena (FAME), Barbacena, MG, Brazil
c University of Alabamaat Birmingham (UAB), Birmingham, AL, USA
a r t i c l e i n f o
Article history:
Received 13 April 2017
Accepted 23 October 2017






a b s t r a c t
Background: Diarrhea is frequently seen in autologous stem cell transplantation. Although
toxicity related to conditioning is the most common cause, infectious pathogens can play a
distinctive role particularly in certain regions and environments.
Methods: The role of enteropathogens was investigated in 47 patients submitted to autol-
ogous stem cell transplantation at a Brazilian center between May 2011 and May 2013. All
patients who presented with diarrhea consented to stool sample analysis to identify the eti-
ological agents including coccidia, Strongyloides sp., Clostridium difficile and other pathogenic
bacteria.
Results: Thirty-nine patients (83%) had diarrhea, among whom seven (17.5%) presented with
coccidia, three (7.5%) with Candida sp., one (2.5%) with C. difficile, and one (2.5%) with Giardia
lamblia. There was a tendency toward a higher incidence of diarrhea in older patients (p-
value = 0.09) and those who received conditioning with lomustine, etoposide, cytarabine, and
melphalan (p-value = 0.083). Furthermore, the number of days of neutropenia was higher in
patients with diarrhea (p-value = 0.06).
Conclusions: The high frequency of diarrhea caused by coccidia shows the importance of
investigating and correctly identifying etiological agents and highlights the possible vari-
eties of intestinal infections in patients who undergo autologous stem cell transplantation.© 2018 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author at: Universidade Federal de Juiz de For a (UFJF), Rua Catulo Breviglieri, s/n, Santa Catarina, CEP: 36036110, Juiz de
Fora, MG, Brazil.
E-mail address: katiaalopes@yahoo.com.br (K.R. Alves).
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2531-1379/© 2018 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. This is an





















































causes. Among the 12 cases of infectious diarrhea, the most
common agents were coccidia in seven cases, among which
four cases were of Cryptosporidium sp. and in three cases it
was not possible to determine the genus of the isolated coc-
cidia. The second most frequent pathogen was Candida spp.
in three cases, including one case where Cryptosporidium sp.







Patients – n (%) 39 (83) 8 (17) 47 (100)
Gender – n (%) 0.60
Male 20 (43) 4 (8.5) 24 (51)
Female 19(40) 4 (8.5) 23 (49)
Age (range/mean) –
years
16–65 19–56 46.2 0.13
Underlying disease – n
(%)
0.47
Multiple myeloma 25 (53) 4 (8.5) 29 (61.5)
Non-Hodgkin’s
lymphoma
4 (8.5) 4 (8.5)
Hodgkin’s
lymphoma
8 (17) 3 (7) 11 (24)
AML 2 (4) 1 (2) 3 (6)
Conditioning – n (%) 0.08
MEL 200 22 (47) 4 (8.5) 26 (45.5)
CBV 3 (7) 3 (7) 6 (14)
LEAM 9 (18.5) 9 (18.5)
Busulfan base
schemes
5 (10) 1 (2) 6 (12)
Febrile neutropenia
(range/mean) – days
1–15 1–7 4.97 0.06hematol transfus cell th
ntroduction
iarrhea is one of the most prevalent causes of morbidity in
atients who undergo autologous stem cell transplantation
ASCT), resulting in a significant impairment to the patient’s
uality of life.1–3 The causes of diarrhea are mainly related to
he toxicity of high-dose chemotherapy schemes, irritation of
he epithelia and mucosa of the digestive tract and various
nfectious conditions.1
Clostridium difficile bacteria is a known cause of diarrhea
f nosocomial origin4 in addition to being associated with
he use of broad-spectrum antimicrobials.5 There is also a
trong association between intestinal infections and oppor-
unistic germs that are present and largely described in groups
f immunocompromised patients submitted to chemother-
py as well as those with oncological diseases or acquired
mmunodeficiency syndrome (AIDS), such as strongyloidiasis,
ryptosporidiosis, isosporiasis, and candidiasis.6
The empirical use of antimicrobials to treat these microor-
anisms is common practice in some ASCT centers.1 However,
here are few studies regarding the etiology or the infections
hat may be involved in diarrheal events, especially in Brazil.
he objective of this study is to identify the main etiologies of
iarrhea in our environment.
ethods
nce approval of the study was granted by the institutional
esearch and ethics committee, all patients evaluated and sub-
itted to ASCT at the bone marrow transplantation unit of the
niversity Hospital of the Universidade Federal de Juiz de Fora
UFJF) between May 2011 and May 2013 were enrolled in this
tudy consecutively.
All patients were evaluated by a parasitological stool exam-
nation and treated according to the pathogen found prior to
SCT since no patient presented with diarrhea at the time of
he transplant procedure. Diarrhea was defined as the pres-
nce of two or more watery or loose fecal discharges within a
4-hour period. Diarrhea was classified as infectious in nature
n cases in which enteric pathogens, intestinal parasites, or
ungi were isolated or in the case of a positive test for A/B
oxin for C. difficile. Afebrile patients who presented with diar-
hea with no isolated infectious agents were considered as
aving chemotherapy-induced diarrhea and the others were
efined as having diarrhea of an unspecified cause.
Parasitological stool examinations using the merthiolate-
odine-formalin and Baermann-Moraes techniques were
onducted in three samples to assess the causes of infections
n patients presenting with diarrhea. Fresh samples were col-
ected for the direct assessment of fungi and coccidia as well
s the assessment of the combined A and B C. difficile tox-
ns using an enzyme-linked immunosorbent assay. Fresh stool
ultures were performed for Shigella sp., Salmonella sp., and
scherichia coli. Other samples were collected from patients
ho stopped having diarrhea for 24 hours but suffered further
pisodes at any time, and a new sample for C. difficile was col-
ected from patients who presented with diarrhea and a new
pisode of fever.0 1 8;40(2):132–135 133
All patients received prophylactic acyclovir from the begin-
ning of the chemotherapy conditioning up to neutrophil
engraftment without prophylaxis for bacteria and fungi.
Cefepime was the empirical antimicrobial used initially for all
patients in the event of fever during neutropenia.
Statistical analysis was conducted using Statistical Package
for the Social Sciences (SPSS) software version 21, in which
Pearson’s chi-squared test or Fisher’s exact test for categori-
cal variables as well as the Mann–Whitney test for variables
with non-normal distribution were used. p-values < 0.05 were
considered statistically significant.
Results
This study enrolled 47 patients (Table 1). Among these
patients, 39 had diarrhea, including one patient who had two
distinct episodes giving a total of 40 events of diarrhea in
the study period. Fourteen patients presented with diarrhea
induced by chemotherapy, with no relationship between the
conditioning chemotherapy protocol used and the presence
of diarrhea, and 14 events were classified as having otherAML: acute myeloid leukemia; MEL 200: melphalan 200 mg/m2; CBV:
cyclophosphamide, carmustine, and etoposide; LEAM: lomustine,
etoposide, cytarabine, and melphalan.
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Table 2 – Distribution of the diarrhea causes in
autologous stem cell transplantation at the institution.
Diarrhea causes Episodes (n) Percent (%)
Quantity induced 14 35.0
Unspecified 14 35.0
Infectious agent 12 30.0
Coccidia 7 17.5
Candida spp. 3 7.5
Clostridium difficile 1 2.5
r
Giardia lamblia 1 2.5
Total 40 100.0
was also isolated from the same sample. There was only one
case of diarrhea caused by C. difficile and one case of Giar-
dia lamblia (Table 2). All of the stool cultures were negative
for enteropathogenic bacteria. Due to the small number of
patients, it was decided not to correlate the causes of diarrhea
with the underlying disease.
There was no difference in the incidence of diarrhea in
relation to gender, underlying disease, days of neutropenia,
presence of fever, or use of antimicrobials. There was no sta-
tistical difference between a higher frequency of diarrhea and
age of patients ≥50 years (p-value = 0.09). All of the patients
who received the LEAM (lomustine, etoposide, cytarabine, and
melphalan)7 protocol developed diarrhea.
The patients who were specifically treated for the isolated
diarrhea-causing agents had an average of 5.3 days of diarrhea,
while those who were not treated specifically had an average
of eight days of diarrhea (p-value = 0.13).
There was no statistically significant correlation between
febrile neutropenia and more days of neutropenia in patients
with diarrhea (p-value = 0.06); in eight of 12 infectious diar-
rhea events, patients had a neutrophil count <500 L when
diarrhea began. There was no correlation between the use of
antibiotics and the frequency of diarrhea considering that all
patients took cefepime upon the development of fever and
neutropenia, including the eight patients who did not present
with diarrhea. Of the 39 patients with diarrhea, only 23%
used cefepime before the diarrhea started. The use of other
antimicrobials, such as vancomycin and carbapenem, had no
correlation with the presence of diarrhea.
Discussion
Diarrhea is a very common event in patients submitted to
ASCT, with frequencies in the literature of 47–91%.1,2,8,9 In
our environment, 83% of the assessed patients presented with
diarrhea, an important cause of morbidity that decreases the
quality of life of these patients.3
Despite the varying frequencies in different reports in
the literature,1,2,10 C. difficile was uncommon as the cause
of diarrhea in our environment, thus the empirical use of
antimicrobial treatment with actions against this pathogen is
not justified, even for patients using broad-spectrum antimi-
crobials such as fourth-generation cephalosporins for the
treatment of febrile neutropenia.
Coccidia were present in approximately 18% of the patients
with diarrhea, and this was the main cause of infec-
tious diarrhea (58% of the isolated agents). These findings. 2 0 1 8;40(2):132–135
demonstrate a frequency that is above that reported in the lit-
erature for ASCT.1 This is probably due to its high prevalence
in developing nations such as Brazil, in which the positivity
rates in patients with AIDS are between 8.1 and 21.4%. There
are some types of parasites that are endemic in develop-
ing countries and are associated with situations that lead to
immunodeficiency.11,12
Despite showing no statistically significant difference, the
diarrhea tended to be shorter in duration in those patients
who were treated for an infectious agent compared to those
who did not have an infectious cause, confirming the infec-
tious etiology of the diarrhea in the patients who received
antimicrobial treatment. One study showed that oral van-
comycin is effective in almost 100% of critically ill patients
infected with C. difficile.4
An investigation of infectious events conducted retrospec-
tively in the same center,13 without performing a systematic
study of the infectious agents in patients with diarrhea, iden-
tified only three cases of coccidia (two Cryptosporidium sp. and
one Isospora sp.) in 72 patients with diarrhea. Therefore, a rou-
tine evaluation of pathogens in diarrheal stools is required,
especially if the condition begins during the period of neu-
tropenia as in 66.6% of the infectious diarrhea events in the
current study; these patients had a neutrophil count <500 L.
Despite high-dose chemotherapy having been the main
cause of diarrhea, in light of the fact that 30% of diarrhea
episodes are related to infections and nearly 18% are caused by
coccidia, the need to identify infectious agents to adequately
treat diarrhea in patients submitted to ASCT is evident. Given
these signs, clinicians must be attentive to the presence of
coccidia in the environment.
Although this study involved a small number of heteroge-
neous patients, clinicians should be alert to diarrhea events
in immunosuppressed populations.
Conflicts of interest
The authors declare no conflicts of interest.
Acknowledgments
We thank all those who contributed to data collection and
analysis.
e f e r e n c e s
1. Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium
difficile-associated disease in human stem cell transplant
recipients: coming epidemic or false alarm? Bone Marrow
Transplant. 2008;42(11):705–13.
2. Arango JI, Restrepo A, Schneider DL, Callander NS,
Ochoa-Bayona JL, Restrepo MI. Incidence of Clostridium
difficile-associated diarrhea before and after autologous blood
stem cell transplantation for lymphoma and multiple
myeloma. Bone Marrow Transplant. 2006;37(5):517–21.3. Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL,
Mobley GM, et al. Symptom burden in patients undergoing






13. Santos KB, Hallack Neto AE, Silva GA, Atalla A, Abreu MM,hematol transfus cell th
4. Musher DM, Aslam S. Treatment of Clostridium difficile colitis
in the critical care setting. Crit Care Clin. 2008;24(2):279–91.
5. Nomura K, Fujimoto Y, Yamashita M, Morimoto Y, Ohshiro M,
Sato K, et al. Absence of pseudomembranes in Clostridium
difficile-associated diarrhea in patients using
immunosuppression agents. Scand J Gastroenterol.
2009;44(1):74–8.
6. Detrait M, Poirier L, Roy DC, Kiss T, Busque L, Cohen S, et al.
Diphyllobothriasis, a rare cause of profuse diarrhea following
autologous transplantation. Bone Marrow Transplant.
2009;44(2):131–2.
7. dos Santos KB, Costa LJ, Atalla A, Pereira J, Hallack Neto AE.
Maximum tolerated dose of lomustine in combination with
etoposide, cytarabine and melphalan in autologous
hematopoietic stem cell transplantation in patients with
lymphoma. Bone Marrow Transplant. 2014;49(9):1239–40.
8. van Kraaij MG, Dekker AW, Verdonck LF, van Loon AM, Vinjé J,
Koopmans MP, et al. Infectious gastroenteritis: an uncommon
cause of diarrhea in adult allogeneic and autologous stem cell
transplant recipients. Bone Marrow Transplant.
2000;26(3):299–303.
9. Avery R, Pohlman B, Adal K, Bolwell B, Goldman M, Kalaycio
M, et al. High prevalence of diarrhea but infrequency of0 1 8;40(2):132–135 135
documented Clostridium difficile in autologous peripheral
blood progenitor cell transplant recipients. Bone Marrow
Transplant. 2000;25(1):67–9.
0. Alonso CD, Dufresne SF, Hanna DB, Labbé AC, Treadway SB,
Neofytos D, et al. Clostridium difficile infection after adult
autologous stem cell transplantation: a multicenter study of
epidemiology and risk factors. Biol Blood Marrow Transplant.
2013;19(10):1502–8.
1. Bachur TP, Vale JM, Coêlho IC, Queiroz TR, Chaves CS. Enteric
parasitic infections HIV/AIDS patients before and after the
highly active antiretroviral therapy. Braz J Infect Dis.
2008;12(2):115–22.
2. Brantley RK, Williams KR, Silva TM, Sistrom M, Thielman NM,
Ward H, et al. AIDS-associated diarrhea and wasting in
northeast Brazil is associated with subtherapeutic plasma
levels of antiretroviral medications and with both bovine and
human subtypes of Cryptosporidium parvum. Braz J Infect Dis.
2003;7(1):16–22.Ribeiro LC. Infection profile of patients undergoing
autologous bone marrow transplantation in a Brazilian
institution. Sao Paulo Med J. 2012;130(1):10–6.
